Brazilian volunteer in Oxford University’s Covid vaccine trial has died – Astrazeneca claims it was the placebo

Possibly the placebo? Really? How does one die ‘coincidentally’ of a placebo dose in a trial? EWR

The Brazilian National Health Surveillance Agency (Anvisa) says it was notified of the death during the Oxford vaccine trial on Monday, October 19, and announced the tragic news on Wednesday, Gazeta Brasil reports.

The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian.

Brazilian news site Globo reports that the volunteer was just 28 years old.

It has not been confirmed whether the volunteer received a placebo dose or the real vaccine, but Globo claims sources have said the volunteer received a placebo dose.

Anvisa has released little information about the volunteer citing medical confidentiality, but says the clinical trials will continue within the country.

READ MORE:

https://www.dailystar.co.uk/news/latest-news/breaking-brazilian-volunteer-oxford-universitys-22884437?fbclid=IwAR18URDO0-MhiEmoGNl2v4TMxVn_w1ad2UkL0hZXTEGrHMnWttj3vyDNtLw

RELATED: Subject who died in AstraZeneca’s COVID-19 vaccine trial was killed by the “placebo” (claims AstraZeneca)

Image by Bruno /Germany from Pixabay

One thought on “Brazilian volunteer in Oxford University’s Covid vaccine trial has died – Astrazeneca claims it was the placebo”

  1. Placebo does not necessarily mean inert these days. You need to find out what is being used in the control group–it could have been an adjuvant or another vaccine.

    And I really don’t know why everyone is calling these things vaccines. They are not. They will modify the human genome.

    Who knows–you could end up with a nice bark!

    Liked by 1 person

Comments are closed.